Cancer Research Annual Meeting 2010 Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antosiewicz, J.
Right arrow Articles by Singh, S. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antosiewicz, J.
Right arrow Articles by Singh, S. V.
[Cancer Research 66, 5379-5386, May 15, 2006]
© 2006 American Association for Cancer Research

Experimental Therapeutics, Molecular Targets, and Chemical Biology

c-Jun NH2-Terminal Kinase Signaling Axis Regulates Diallyl Trisulfide–Induced Generation of Reactive Oxygen Species and Cell Cycle Arrest in Human Prostate Cancer Cells

Jedrzej Antosiewicz, Anna Herman-Antosiewicz, Stanley W. Marynowski and Shivendra V. Singh

Department of Pharmacology and Urology and University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Requests for reprints: Shivendra V. Singh, Department of Pharmacology, 2.32A Hillman Cancer Center Research Pavilion, University of Pittsburgh Cancer Institute, 5117 Centre Avenue, Pittsburgh, PA 15213. Phone: 412-623-3263; Fax: 412-623-7828; E-mail: singhs{at}upmc.edu.


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We have shown previously that generation of reactive oxygen species (ROS) is a critical event in G2-M phase cell cycle arrest caused by diallyl trisulfide (DATS), which is a highly promising anticancer constituent of processed garlic. Using DU145 and PC-3 human prostate cancer cells as a model, we now report a novel mechanism involving c-Jun NH2-terminal kinase (JNK) signaling axis, which is known for its role in regulation of cell survival and apoptosis, in DATS-induced ROS production. The DATS-induced ROS generation, G2-M phase cell cycle arrest and degradation, and hyperphosphorylation of Cdc25C were significantly attenuated in the presence of EUK134, a combined mimetic of superoxide dismutase and catalase. Interestingly, the DATS-induced ROS generation and G2-M phase cell cycle arrest were also inhibited significantly in the presence of desferrioxamine, an iron chelator, but this protection was not observed with iron-saturated desferrioxamine. DATS treatment caused a marked increase in the level of labile iron that was accompanied by degradation of light chain of iron storage protein ferritin. Interestingly, DATS-mediated degradation of ferritin, increase in labile iron pool, ROS generation, and/or cell cycle arrest were significantly attenuated by ectopic expression of a catalytically inactive mutant of JNK kinase 2 and RNA interference of stress-activated protein kinase/extracellular signal-regulated kinase 1 (SEK1), upstream kinases in JNK signal transduction pathway. In conclusion, the present study provides experimental evidence to indicate existence of a novel pathway involving JNK signaling axis in regulation of DATS-induced ROS generation. (Cancer Res 2006; 66(10): 5379-86)


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Epidemiologic data continue to lend support to the premise that dietary intake of Allium vegetables, including garlic, may be protective against the risk of various types of malignancies, including cancer of the prostate (1–4). For example, the risk of prostate cancer was shown to be significantly lower in men consuming >10 g/d of total Allium vegetables than in men with total Allium vegetable intake of <2.2 g/d in a population-based case-control study (4). Anticarcinogenic effect of Allium vegetables is attributed to organosulfur compounds (OSC), which are released upon processing (e.g., cutting or chewing) of these vegetables (5, 6). Allium vegetable–derived OSCs, including diallyl sulfide, diallyl disulfide (DADS), and/or diallyl trisulfide (DATS), have been shown to inhibit cancer in animal models induced by a variety of carcinogens, including tobacco smoke–derived chemicals (7–11). For instance, the naturally occurring OSC analogues are highly effective in affording protection against benzo(a)pyrene-induced forestomach and pulmonary carcinogenesis in mice (8), N-nitrosomethylbenzylamine-induced esophageal cancer in rats (9), azoxymethane-induced colonic aberrant crypt foci formation in rats (10), and N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats (11). The OSCs are believed to inhibit chemically induced cancers by increasing the expression of phase 2 carcinogen-inactivating enzymes, including glutathione (GSH) transferases and quinone reductase, and/or by inhibiting cytochrome P450–dependent monooxygenases (12–14). We have also shown previously that oral administration of DADS significantly inhibits growth of H-ras oncogene–transformed tumor xenografts in athymic mice without causing weight loss or any other side effects (15).

Evidence is accumulating to indicate that some naturally occurring OSC analogues, including DATS, can inhibit proliferation of cultured cancer cells by causing apoptosis and cell cycle arrest (16–24). An understanding of the mechanism by which OSCs cause apoptosis and cell cycle arrest is critical for their further development as clinically useful anticancer agents because this knowledge could lead to identification of mechanism-based biomarkers potentially useful in future clinical trials. The OSC-mediated apoptosis induction and cell cycle arrest was first documented by Milner (16, 17). The DADS-induced apoptosis in HCT-15 human colon cancer cells correlated positively with an increase in the level of intracellular free calcium (16). Our own work has revealed that the DATS-induced apoptosis in PC-3 and DU145 human prostate cancer cell lines is mediated by down-regulation as well as hyperphosphorylation of Bcl-2 (20). Despite considerable progress towards our understanding of the signaling pathways leading to OSC-mediated apoptosis (reviewed in ref. 21), the mechanism of cell cycle arrest caused by garlic-derived OSCs is not fully understood.

Recently, we investigated the mechanism of DATS-induced cell cycle arrest using DU145 and PC-3 cells as a model (22, 23). We found that the DATS-induced G2-M phase cell cycle arrest in our model is independent of p21 but linked to reactive oxygen species (ROS)–dependent destruction and Ser216 phosphorylation of cell division cycle 25C (Cdc25C) protein. The net result of these effects is accumulation of Tyr15-phosphorylated (inactive) cyclin-dependent kinase 1 (Cdk1), whose activation is critical for G2-M transition. However, the mechanism by which DATS treatment causes ROS generation remains elusive. We now provide experimental evidence to indicate that the DATS-induced ROS generation in DU145 and PC-3 cells is caused by an increase in labile iron pool due to degradation of ferritin mediated by c-Jun NH2-terminal kinase (JNK) signaling axis. The present study is the first published report to implicate JNK signaling axis, which is best known for its role in regulation of cell survival and cell death (25–28), in regulation of ferritin stability, iron homeostasis, and ROS generation.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Reagents. DATS was purchased from LKT Laboratories (St. Paul, MN). Tissue culture media, antibiotic mixture, and fetal bovine serum were from Life Technologies (Grand Island, NY). RNaseA was from Promega (Madison, WI). Propidium iodide and desferrioxamine mesylate were from Sigma (St. Louis, MO). 6-Carboxy-2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA) and hydroethidine were from Molecular Probes (Eugene, OR). Combined superoxide dismutase and catalase mimetic EUK134 was a generous gift from Eukarion, Inc. (Bedford, MA). The antibodies against Cdc25C, phospho-(Ser216)-Cdc25C, ferritin L, and ferritin H were from Santa Cruz Biotechnology (Santa Cruz, CA). The antibody against total ferritin was from Sigma, and anti-actin antibody was from Oncogene Research Products (Boston, MA). The antibody against SEK1 was from Cell Signaling Technology (Beverly, MA). GSH level was determined using a kit from Cayman Chemical (Ann Arbor, MI). The JNK kinase activity was determined using a kit from Cell Signaling Technology.

Cell lines and cell culture. Monolayer cultures of PC-3 cells were maintained in F-12K Nutrient Mixture (Kaighn's modification) supplemented with 7% non–heat-inactivated fetal bovine serum and antibiotics. The DU145 cells were cultured in DMEM supplemented with 10% fetal bovine serum, 0.1 mmol/L nonessential amino acids, 1 mmol/L sodium pyruvate, and antibiotics. Each cell line was maintained at 37°C in an atmosphere of 95% air and 5% CO2.

Measurement of ROS. Intracellular ROS generation was measured by flow cytometric monitoring of oxidation of H2DCFDA, which is cleaved by nonspecific cellular esterases and oxidized in the presence of peroxides, including hydrogen peroxide, to yield fluorescent 2',7'-dichlorofluorescein (DCF; refs. 29, 30). Briefly, 2 x 105 cells were plated, allowed to attach overnight, and exposed to desired concentration of DATS for specified time period. Stock solution of DATS was prepared in DMSO, and an equal volume of DMSO was added to the controls. Subsequently, the cells were counterstained with 2 µmol/L hydroethidine and 5 µmol/L H2DCFDA for 30 minutes at 37°C. The cells were collected, and the fluorescence was analyzed using a Coulter Epics XL Flow Cytometer. In some experiments, cells were treated with DATS in the absence or presence of 20 µmol/L EUK134, 25 µmol/L desferrioxamine, or 25 µmol iron-saturated desferrioxamine (2-hour pretreatment) before analysis of ROS generation.

Analysis of cell cycle distribution. The effect of DATS treatment on cell cycle distribution was determined by flow cytometry following staining with propidium iodide. Briefly, DU145 or PC-3 cells (1 x 106) were seeded in T75 flasks and allowed to attach by overnight incubation. The cells were then exposed to desired concentrations of DATS for specified time periods at 37°C. Both floating and adherent cells were collected, washed with PBS, and fixed with 70% ethanol. The fixed cells were treated with RNaseA and propidium iodide, and the stained cells were analyzed using a Coulter Epics XL Flow Cytometer as described by us previously (22, 23, 31). In some experiments, the cells were treated with DATS in the absence or presence of 20 µmol/L EUK134, 25 µmol/L desferrioxamine, 25 µmol/L iron-saturated desferrioxamine, or 1 µmol/L MG132 (2-hour pretreatment) before analysis of cell cycle distribution.

Immunoblotting. The cells were treated with DATS and/or EUK134 or MG132 as described above. Both floating and attached cells were collected; washed with PBS; resuspended in a lysis solution containing 50 mmol/L Tris-HCl (pH 8), 150 mmol/L NaCl, 0.1% SDS, 1% Triton X-100, 10 µg/mL phenanthroline, 10 µg/mL aprotinin, 10 µg/mL leupeptin, 10 µg/mL pepstatin A, 1 mmol/L phenylmethylsulfonyl fluoride; and incubated for 40 minutes on ice with gentle shaking. The cell lysate was cleared by centrifugation at 18,000 x g for 20 minutes. Lysate proteins were resolved by 10% to 12% SDS-PAGE and subjected to immunoblotting as described previously (32, 33). Change in protein level was assessed by densitometric scanning of the bands and corrected for actin loading control.

Determination of GSH level. The effect of DATS treatment on intracellular GSH level was determined using a kit from Cayman Chemical according to the manufacturer's instructions. Briefly, PC-3 or DU145 cells (1 x 106) were plated, allowed to attach, and exposed to DMSO (control) or 40 µmol/L DATS for specified time intervals at 37°C. The cells were collected by scraping, washed with PBS, resuspended in 0.5 mL of PBS, and counted. Equal number of cells from each treatment group was processed for analysis of GSH.

Determination of labile iron. The effect of DATS treatment on level of labile iron was determined by (a) a modified high-pressure liquid chromatography (HPLC) procedure described by Gower et al. (34) and (b) analysis of calcein fluorescence as described by Breuer et al. (35). The HPLC method detects desferrioxamine chelatable iron in cellular extracts. Briefly, cells (6 x 106) were treated with 40 µmol/L DATS for specified time periods, collected by trypsinization, and washed twice with PBS. Cells were lysed by five cycles of freeze-thaw, and cellular extracts were suspended in 1 mL of 50 mmol/L Tris-HCl (pH 7.4) containing 2 mmol/L desferrioxamine. The samples were incubated for 1 hour at 37°C and centrifuged for 15 minutes at 15,000 x g. The desferrioxamine and ferrioxamine in the supernatant fractions were extracted using a Sep-Pak C18 cartridges (Waters, Boston, MA) presoaked with methanol, and conditioned with distilled water. The supernatants were then applied to the Sep-Pak C18 cartridge and washed with water, and desferrioxamine and ferrioxamine were eluted with methanol. The eluted material was dried under vacuum, reconstituted, and subjected to reversed-phase HPLC using a Waters 600E controller equipped with a 717 plus autosampler, 996 photodiode array detector, and Nova-Pak C18 reversed-phase column (150 mm x 3.9 mm; particle size = 4 µm). The mobile phase consisted of 20 µmol/L sodium phosphate buffer (pH 6.6) containing 4 mmol/L EDTA, 1 mol/L ammonium acetate, and 10% (v/v) acetonitrile. Elution was carried out isocratically at a column flow rate of 0.75 mL/min. Eluates were monitored at 240 nm. For determination of calcein fluorescence, cells were seeded at a density of 1 x 105 per well, allowed to attach, and exposed to 40 µmol/L DATS in the absence or presence of 25 µmol/L desferrioxamine or 1 µmol/L MG132 (2-hour pretreatment). Cells were then stained with 5 µmol/L calcein for 30 minutes and rinsed with PBS, and calcein fluorescence was examined using a Leica fluorescence microscope.

Transient transfection. Plasmid expressing catalytically inactive mutant of JNK kinase 2 [JNKK2(AA)] was kindly provided by Dr. Michael Karin (36). DU145 cells were transfected with the plasmid encoding inactive JNKK2(AA) or empty pcDNA3.1 vector at 50% to 60% confluency using FuGENE 6 (Roche, Indianapolis, IN). After 24 hours of transfection, the cells were treated with DATS and processed for different assays. The DU145 cells stably transfected with pSilencer-SEK1 small interfering RNA (siRNA) or empty vector were generously provided by Dr. Yong J. Lee (37).

Immunoprecipitation-immunoblotting to determine ferritin ubiquitination. Cells were treated with DATS for specified time periods, washed twice with ice-cold PBS, and lysed as described above. Aliquots containing 800 µg of lysate protein were incubated with 3 µg of anti-ferritin antibody overnight at 4°C. Protein A/G plus-agarose (30 µL; Santa Cruz Biotechnology) was then added to each sample, and the incubation was continued for an additional 3 hours at 4°C. The immunoprecipitated complexes were washed five times with lysis buffer and subjected to SDS-PAGE followed by immunoblotting using anti-ubiquitin antibody.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
ROS dependence of DATS-induced cell cycle arrest. We have shown previously that the DATS-induced G2-M phase cell cycle arrest in DU145 and PC-3 cells is associated with ROS-dependent destruction and Ser216 phosphorylation of Cdc25C (22). In the present study, we used a combined mimetic of superoxide dismutase and catalase (EUK134) to firmly establish the association between DATS-induced ROS production and cell cycle arrest. Figure 1A summarizes data on effect of EUK134 on DATS-mediated oxidation of H2DCFDA, a measure of ROS production. Treatment of DU145 cells with 40 µmol/L DATS for 4 hours resulted in an ~2.5-fold increase in DCF fluorescence compared with DMSO-treated control (Fig. 1A). The DATS-mediated oxidation of H2DCFDA was evident as early as 1 hour after treatment and observed even at lower drug concentrations (data not shown). The DATS-mediated oxidation of H2DCFDA was nearly completely blocked in the presence of 20 µmol/L EUK134 (Fig. 1A). As can be seen in Fig. 1B, treatment of DU145 cells with 40 µmol/L DATS for 8 hours resulted in an ~2.3-fold enrichment of G2-M fraction compared with DMSO-treated control. The DATS-induced G2-M phase cell cycle arrest was partially but statistically significantly attenuated in the presence of EUK134 (P < 0.05, DATS alone group versus DATS plus EUK134 group by one-way ANOVA followed by Bonferroni's multiple comparison test; Fig. 1B). Moreover, EUK134 offered a marked protection against DATS-induced degradation and Ser216 phosphorylation of Cdc25C (Fig. 1C). Collectively, these results indicated that ROS generation was a critical event in DATS-induced G2-M phase cell cycle arrest.


Figure 1
View larger version (15K):
[in this window]
[in a new window]
  		Figure 1. Superoxide dismutase and catalase mimetic EUK134 inhibits DATS-induced ROS generation and G2-M phase cell cycle arrest in DU145 cells. A, % cells with high DCF fluorescence (a measure of ROS production) in DU145 cultures treated with DATS in the absence or presence of EUK134. The DU145 cells were plated, allowed to attach overnight, and exposed to DMSO (control) or 20 µmol/L EUK134 for 2 hours. The cells were either left untreated (DMSO and EUK134 alone groups) or exposed to 40 µmol/L DATS for 4 hours before analysis of DCF fluorescence by flow cytometry. Columns, mean (n = 3); bars, SE. a, P < 0.05, significantly different compared with DMSO-treated control; b, P < 0.05, significantly different compared with DATS alone group by one-way ANOVA followed by Bonferroni's multiple comparison test. Similar results were observed in two independent experiments. B, % G2-M fraction in DU145 cultures treated for 8 hours with 40 µmol/L DATS in the absence or presence of 20 µmol/L EUK134 (2-hour pretreatment). Columns, mean (n = 3 except for EUK134 alone group where n = 2); bars, SE. a, P < 0.05, significantly different compared with DMSO-treated control; b, P < 0.05, significantly different compared with DATS alone group by one-way ANOVA followed by Bonferroni's multiple comparison test. Similar results were observed in two independent experiments. C, immunoblotting for Cdc25C and phospho-Cdc25C (Ser216) using lysates from DU145 cells treated for 8 hours with 40 µmol/L DATS in the absence or presence of 20 µmol/L EUK134 (2-hour pretreatment). Blots were stripped and reprobed with anti-actin antibody to ensure equal protein loading. Densitometric scanning data after correction for actin loading control are on top of Cdc25C and p-Cdc25C immunoreactive bands.

 
Iron chelation prevented DATS-induced ROS generation. Although a role for oxidative stress in cellular responses to DADS and DATS has been suggested in other cellular systems (19, 24), the mechanism by which OSCs cause ROS production remains elusive. Initially, we considered the possibility that DATS-induced ROS production might be due to depletion of intracellular GSH, which is the predominant non-protein thiol in cells. We explored this possibility by measuring GSH levels in PC-3 and DU145 cells following treatment with DMSO (control) or 40 µmol/L DATS for 1, 4, or 8 hours. DATS treatment did not affect intracellular GSH level in either DU145 or PC-3 cell line (data not shown). These results indicated that ROS production in DATS-treated DU145/PC-3 cells was not caused by depletion of GSH levels.

Labile iron is considered an important determinant of ROS generation in cells because even trace amounts of labile iron can cause oxidative stress through Fenton/Haber-Weiss reactions (38, 39). Therefore, we tested the possibility whether ROS production in our model was iron-dependent by using an iron chelator desferrioxamine. As can be seen in Fig. 2A , the DATS-induced oxidation of H2DCFDA in DU145 cells was reduced below control level in the presence of 25 µmol/L desferrioxamine. The DU145 cells treated with desferrioxamine alone also exhibited statistically significant decrease in H2DCFDA oxidation compared with DMSO-treated control, which is consistent with involvement of iron in ROS production (38, 39). We used iron-saturated desferrioxamine (DFO-Fe) as a control to confirm iron dependence of DATS-induced ROS production. Unlike desferrioxamine, iron-saturated desferrioxamine did not offer protection against DATS-induced ROS generation (Fig. 2A). The protective effect of desferrioxamine, but not iron-saturated desferrioxamine, against DATS-mediated ROS production was also observed in PC-3 cells (Fig. 2B). These results suggested that the DATS-induced ROS generation in DU145 and PC-3 cells might be caused by an increase in labile iron.


Figure 2
View larger version (13K):
[in this window]
[in a new window]
  		Figure 2. Iron chelator desferrioxamine (DFO) protects against DATS-induced ROS production in DU145 and PC-3 cells. A, % cells with high DCF fluorescence in DU145 cultures treated for 1 hour with 40 µmol/L DATS in the absence or presence of 25 µmol/L desferrioxamine or iron-saturated desferrioxamine (DFO-Fe) (2-hour pretreatment). Columns, mean (n = 3); bars, SE. a, P < 0.05, significantly different compared with DMSO-treated control; b, P < 0.05, significantly different compared with DATS alone group by one-way ANOVA followed by Bonferroni's multiple comparison test. B, % cells with high DCF fluorescence in PC-3 cultures treated for 4 hours with 40 µmol/L DATS in the absence or presence of 25 µmol/L desferrioxamine or iron-saturated desferrioxamine (2-hour pretreatment). Columns, mean (n = 3); bars, SE. a, P < 0.05, significantly different compared with DMSO-treated control; b, P < 0.05, significantly different compared with DATS alone group by one-way ANOVA followed by Bonferroni's multiple comparison test. Similar results were observed in two independent experiments.

 
Desferrioxamine protected against DATS-induced G2-M arrest. Next, we determined the effect of desferrioxamine on DATS-induced cell cycle arrest, and the results are summarized in Fig. 3 . Exposure of DU145 (Fig. 3A) and PC-3 (Fig. 3B) cells to 40 µmol/L DATS for 8 hours resulted in about 2.6- and 1.9-fold increase, respectively, in percentage of cells with G2-M phase DNA content compared with DMSO-treated control. The DATS-induced G2-M phase cell cycle arrest was statistically significantly attenuated (P < 0.05, DATS alone group versus DATS + desferrioxamine group by one-way ANOVA followed by Bonferroni's multiple comparison test) in the presence of desferrioxamine in both cell lines (Fig. 3). Similar to ROS generation, however, the DATS-induced G2-M block was not affected in the presence of iron-saturated desferrioxamine (Fig. 3). These results indicated that the DATS-induced cell cycle arrest in both cell lines was dependent on availability of labile iron.


Figure 3
View larger version (11K):
[in this window]
[in a new window]
  		Figure 3. Iron chelator desferrioxamine (DFO) inhibits DATS-induced G2-M phase cell cycle arrest in DU145 and PC-3 cells. Percentage of G2-M fraction in (A) DU145 cultures and (B) PC-3 cultures treated for 8 hours with 40 µmol/L DATS in the absence or presence of 25 µmol/L desferrioxamine or iron-saturated desferrioxamine (DFO-Fe) (2-hour pretreatment). The DU145 or PC-3 cells were plated, allowed to attach overnight, and exposed to DMSO (control) or 25 µmol/L desferrioxamine or iron-saturated desferrioxamine for 2 hours. The cells were either left untreated (DMSO and desferrioxamine alone groups) or exposed to 40 µmol/L DATS for 8 hours before propidium iodide staining and analysis of cell cycle distribution by flow cytometry. Columns, mean (n = 4); bars, SE. a, P < 0.05, significantly different compared with DMSO-treated control; b, P < 0.05, significantly different compared with DATS alone group by one-way ANOVA followed by Bonferroni's multiple comparison test.

 
DATS treatment increased labile iron by promoting ferritin degradation. Ferritin is an iron storage protein whose degradation leads to liberation of chelatable iron (40, 41). As can be seen in Fig. 4A , treatment of DU145 cells with 40 µmol/L DATS resulted in a time-dependent decrease in the protein levels of light (ferritin L) and heavy chains of ferritin (ferritin H), although the decrease in ferritin L protein level was relatively more pronounced compared with ferritin H. The DATS-mediated decrease in ferritin L protein level in DU145 cells was evident as early as 1 hour after treatment and increased progressively with increasing exposure time (Fig. 4A).


Figure 4
View larger version (26K):
[in this window]
[in a new window]
  		Figure 4. DATS treatment increases labile iron by causing ferritin degradation. A, immunoblotting for ferritin L and ferritin H using lysates from DU145 cells treated with 40 µmol/L DATS for the indicated time periods. Blots were stripped and reprobed with anti-actin antibody to ensure equal protein loading. Densitometric scanning data after correction for actin loading control are above ferritin L and ferritin H immunoreactive bands. B, labile iron in DU145 and PC-3 cells treated with 40 µmol/L DATS for the indicated time periods. The labile iron was measured by a modified HPLC procedure described by Gower et al. (34). Columns, mean (n = 4-8); bars, SE. *, P < 0.05, significantly different compared with corresponding control by unpaired t test (DU145 cells) or one-way ANOVA followed by Bonferroni's multiple comparison test (PC-3 cells). C, calcein fluorescence in DU145 cells treated with (a) DMSO for 4 hours (control), (b) 40 µmol/L DATS for 4 hours, (c) 40 µmol/L DATS for 4 hours in the presence of 25 µmol/L desferrioxamine (2-hour pretreatment), (d) 25 µmol/L desferrioxamine alone (6 hours), (e) 40 µmol/L DATS for 4 hours in the presence of 1 µmol/L MG132 (2-hour pretreatment), and (f) 1 µmol/L MG132 alone (6 hours). D, % G2-M fraction in DU145 cells treated for 8 hours with 40 µmol/L DATS in the absence or presence of 1 µmol/L MG132 (2-hour pretreatment). Columns, mean (n = 3); bars, SE. a, P < 0.05, significantly different compared with DMSO-treated control; b, P < 0.05, significantly different compared with DATS alone group by one-way ANOVA followed by Bonferroni's multiple comparison test. Inset, immunoblotting for ferritin L, ferritin H, and actin using lysates from DU145 cells treated with 40 µmol/L DATS (4 hours) in the absence or presence of 1 µmol/L MG132 (2-hour pretreatment). Similar results were observed in replicate experiments.

 
Next, we directly tested the possibility whether DATS-mediated degradation of ferritin caused an increase in labile iron. The level of labile iron was measured by two independent but complementary methods: (a) analysis of labile iron by an HPLC procedure and (b) fluorescence microscopy after staining with iron-sensitive probe calcein, the fluorescence of which is quenched on binding to non–ferritin-bound iron (35). The HPLC assay revealed a modest yet statistically significant increase in the level of labile iron on treatment of DU145 and PC-3 cells with 40 µmol/L DATS (Fig. 4B). Fluorescence microscopy using calcein confirmed an increase in labile iron in DATS-treated cells (Fig. 4C). In DMSO-treated control DU145 cells, the calcein fluorescence was intense and evenly distributed across the cell (Fig. 4C, a). By contrast, cells treated with DATS (40 µmol/L, 4 hours) exhibited greatly reduced intracellular calcein fluorescence, indicating an increase in non–ferritin-bound labile iron (Fig. 4C, b). We argued that if quenching of calcein fluorescence in DATS-treated cells (Fig. 4B, b) was due to release of iron from intracellular stores, then the calcein fluorescence should be dequenched by trapping the released iron with desferrioxamine to prevent the interaction between free iron and the fluorescent probe. The DATS-mediated quenching of calcein fluorescence was indeed abolished upon 2-hour pretreatment with 25 µmol/L desferrioxamine (Fig. 4C, c), providing further evidence for an increase in labile iron. The desferrioxamine treatment alone did not have any appreciable effect on calcein fluorescence (Fig. 4C, d), which is understandable because an effect on calcein fluorescence is not expected in the absence of labile iron.

Next, we designed experiments to systematically explore the possibility whether DATS-mediated increase in labile iron was associated with proteasomal degradation of ferritin. We addressed this question by using proteasomal inhibitor MG132. As can be seen in Fig. 4C (e), the DATS-mediated quenching of calcein fluorescence was reduced in the presence of MG132, whereas MG132 alone did not have any appreciable effect on calcein fluorescence (Fig. 4C, f). Consistent with these results, MG132 offered a marked protection against DATS-induced degradation of ferritin (Fig. 4D, inset) and cell cycle arrest in DU145 cells (Fig. 4D). These results clearly indicated that DATS treatment promoted proteasome-mediated degradation of ferritin to cause release of labile iron in DU145 cells.

DATS-mediated increase in labile iron was regulated by JNK kinase. Recent studies have indicated that activation of JNK, which is best known for its role in regulation of cell survival and apoptosis in response to different stimuli (25–28), can cause ROS generation in some systems (42, 43). For example, JNK activation has been linked to ROS production by tumor necrosis factor (TNF; ref. 42), although the mechanism of this effect remains elusive. Because our previous work showed rapid activation of JNK in DATS-treated PC-3 and DU145 cells (20), we designed experiments to test a hypothesis that DATS-mediated ROS production in our model was regulated by JNK signaling axis. We tested this hypothesis using DU145 cells transiently transfected with a catalytically inactive mutant of JNKK2, which is a JNK-specific upstream kinase (44). As can be seen in Fig. 5A , DATS treatment (40 µmol/L, 30 minutes) caused an ~2.3-fold increase in the kinase activity of JNK in vector-transfected control DU145 cells as determined by immunoprecipitation kinase assay by monitoring phosphorylation of c-Jun, a down-stream target of JNK. The DATS-mediated activation of JNK was reduced markedly in cells transfected with catalytically inactive JNKK2 (Fig. 5A). Interestingly, DATS-mediated ROS generation was observed in vector-transfected control DU145 cells but not in cells overexpressing catalytically inactive JNKK2 (Fig. 5B). Next, we explored possible involvement of JNKK2 in DATS-mediated degradation of ferritin and increase in labile iron pool. Similar to untransfected DU145 cells (Fig. 4A), DATS treatment caused a marked reduction in protein level of ferritin L (Fig. 5C) in vector-transfected control cells. In addition, DATS treatment caused quenching of calcein fluorescence in vector-transfected DU145 cells (Fig. 5D). DU145 cells overexpressing catalytically inactive JNKK2, where DATS-mediated JNK activation was impaired, were resistant to both DATS-induced degradation of ferritin L (Fig. 5C) and quenching of calcein fluorescence (Fig. 5D). Collectively, these results indicated that the DATS-induced ferritin degradation and increase in labile iron was regulated by JNK signaling axis.


Figure 5
View larger version (22K):
[in this window]
[in a new window]
  		Figure 5. DATS-induced ROS generation is regulated by JNK signaling axis. A, JNK kinase activity using lysates from DU145 cells transiently transfected with empty vector or catalytically inactive mutant of JNK-specific upstream kinase JNKK2 following a 30-minute treatment with DMSO or 40 µmol/L DATS. Similar results were observed in two independent experiments. B, ROS generation in DU145 cells transiently transfected with empty vector or catalytically inactive mutant of JNK specific upstream kinase JNKK2 following a 4-hour treatment with DMSO or 40 µmol/L DATS. Columns, mean (n = 3); bars, SE. a, P < 0.05, significantly different compared with DMSO-treated control by paired t test. C, immunoblotting for ferritin L using lysates from DU145 cells transiently transfected with empty vector or catalytically inactive JNKK2 following a 4-hour treatment with DMSO or 40 µmol/L DATS. The blot was stripped and reprobed with anti-actin antibody to ensure equal protein loading. Similar results were observed in two independent experiments. D, calcein fluorescence in DU145 cells transiently transfected with empty vector or catalytically inactive mutant of JNKK2 following a 4-hour treatment with DMSO or 40 µmol/L DATS. The experiment was repeated, and the results were comparable.

 
We confirmed involvement of JNK signaling axis in regulation of DATS-induced ROS production by RNA interference of SEK1, which is an upstream kinase in JNK signal transduction pathway (25). As shown in Fig. 6A (inset), the protein level of SEK1 was reduced by >85% in DU145 cells stably transfected with SEK1-specific siRNA (hereafter abbreviated as siSEK1#2 cells) compared with cells transfected with empty vector pSilencer 2.1-U6 hygro (hereafter abbreviated as pSilencer cells). Similar to untransfected DU145 cells (Fig. 1A), DATS treatment caused a time-dependent and statistically significant increase in ROS generation in pSilencer cells compared with DMSO-treated control, whereas ROS generation was not observed in siSEK1#2 cells (Fig. 6A). Consistent with these results, DATS and H2O2 (positive control, 25 µmol/L for 30 minutes) treatments resulted in ferritin L degradation in pSilencer cells but not in siSEK1#2 cells (Fig. 6B). We tested the possibility whether DATS treatment caused ubiquitination of ferritin by immunoprecipitation of ferritin followed by immunoblotting using anti-ubiquitin antibody. Polyubiquitin conjugates upon treatment with 40 µmol/L DATS were observed in pSilencer cells but not in siSEK1#2 cells (data not shown). DATS as well as H2O2 treatment caused quenching of calcein fluorescence in vector-transfected control pSilencer cells (Fig. 6C). On the other hand, DATS or H2O2 treatment failed to significantly quench calcein fluorescence in siSEK1#2 cells (Fig. 6C). Moreover, the siSEK1#2 cells were resistant to DATS-induced G2-M phase cell cycle arrest (Fig. 6D). On the other hand, DATS treatment caused a significant increase in G2-M fraction in vector-transfected pSilencer cells compared with DMSO-treated control (Fig. 6D). Collectively, these results indicated that JNK signaling axis regulated DATS-mediated ROS production and cell cycle arrest by controlling ferritin degradation and release of free iron.


Figure 6
View larger version (31K):
[in this window]
[in a new window]
  		Figure 6. DATS-induced ROS generation is attenuated by RNA interference of SEK1. A, % cells with high DCF fluorescence in DU145 cells stably transfected with empty vector (pSilencer cells) or SEK1-specific siRNA (siSEK1#2 cells) following a 2- or 4-hour treatment with DMSO or 40 µmol/L DATS. Columns, mean (n = 3); bars, SE. a, P < 0.05, significantly different compared with respective DMSO-treated control by paired t test. Inset, immunoblotting data for SEK1 using lysates from pSilencer cells or siSEK1#2 cells. The blot was stripped and reprobed with anti-actin antibody to ensure equal protein loading. B, immunoblotting for ferritin L using lysates from pSilencer and siSEK1#2 cells treated with 40 µmol/L DATS for the indicated time periods or 25 µmol/L hydrogen peroxide for 30 minutes (positive control; last lane). The blots were stripped and reprobed with anti-actin antibody to ensure equal protein loading. C, calcein fluorescence in pSilencer and siSEK1#2 cells treated for 4 hours with DMSO (control) or 40 µmol/L DATS. Cells treated for 30 minutes with 25 µmol/L H2O2 were included as positive control. D, % G2-M fraction in pSilencer and siSEK1#2 cultures following 8-hour treatment with DMSO (control) or 40 µmol/L DATS. Columns, mean (n = 3); bars, SE. a, P < 0.05, significantly different compared with DMSO-treated control by paired t test. Similar results were observed in replicate experiments.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
We have shown previously that the DATS-induced G2-M phase cell cycle arrest in PC-3 and DU145 human prostate cancer cells is associated with generation of ROS, which causes rapid degradation and Ser216 phosphorylation of Cdc25C, leading to accumulation of inactive Cdk1 (22). In the present study, we confirmed ROS dependence of DATS-induced cell cycle arrest using an antioxidant EUK134, which is a combined mimetic of superoxide dismutase and catalase. We show that EUK134 confers significant protection not only against DATS-mediated ROS production (Fig. 1A) but also the cell cycle arrest (Fig. 1B) and degradation and hyperphosphorylation of Cdc25C (Fig. 1C). These results clearly indicate that ROS generation is a critical event in DATS-mediated cell cycle arrest in our model. A role for ROS in cellular responses to another garlic-derived OSC (DADS) has been suggested previously (19), but the mechanism by which DADS or DATS cause oxidative stress was unclear.

The main goal of the present study was to gain insights into the mechanism by which DATS causes ROS generation in DU145 and PC-3 cells. We show that the DATS-mediated ROS production in our model is not caused by depletion of GSH level (data not shown); rather, it is associated with an increase in labile iron. Iron is necessary for normal cellular proliferation because iron-containing proteins catalyze various key biochemical processes, such as energy metabolism, respiration, folate metabolism, and DNA synthesis (45). Intracellular iron is either labile (chelatable) or stored by ferritin as a nonchelatable pool (38–41). Although labile iron represents only a minor fraction of total cellular iron pool, it plays an important role in cellular metabolism due to its rapid accessibility (39). Even trace amounts of free iron can lead to generation of highly toxic hydroxyl radicals (38, 39). Repression of ferritin expression has been shown to increase the labile iron, leading to oxidative stress in human erythroleukemia cells (47). The present study reveals that the DATS-induced ROS generation and consequently the cell cycle arrest in DU145 and PC-3 cells is caused by an increase in labile iron due to ferritin degradation. This conclusion is based on the following observations: (a) the DATS-mediated ROS generation and G2-M phase cell cycle arrest in DU145 and PC-3 cells are significantly attenuated in the presence of desferrioxamine (Figs. 2 and 3), which is a chelator of labile iron. (b) The protective effect of desferrioxamine is abolished if it is saturated with iron before addition to the cell culture. (c) The DATS treatment causes a rapid decrease in the protein level of ferritin (Fig. 4A), especially the light chain. (d) The DATS treatment increases the level of labile iron as revealed by HPLC-based quantitation of chelatable iron (Fig. 4B) and quenching of the fluorescence of iron-sensitive probe calcein (Fig. 4C). (e) The DATS-mediated quenching of calcein fluorescence, ferritin degradation, and cell cycle arrest is significantly attenuated in the presence of proteasomal inhibitor MG132. Thus, our data provide support for existence of a signaling mechanism involving ferritin degradation, release of iron, and ROS generation in DATS-induced cell cycle arrest.

The most interesting observation of the present study is that DATS-induced ROS generation in our model is regulated by JNK signaling axis, which is best known for its role in control of cell proliferation and death in response to diverse stimuli, including dietary cancer chemopreventive agents (25–28). Recently, it has been shown that JNK activation by TNF leads to an increase in ROS formation and this effect is significantly reduced in JNK–/– fibroblasts (42). However, the mechanism of JNK-dependent ROS formation by TNF was not explained. We now show that the DATS-induced ROS generation and cell cycle arrest in our model is linked to JNK activation. This conclusion stems from the observations that DATS-induced ROS production and cell cycle arrest are significantly attenuated by ectopic expression of a catalytically inactive mutant of the upstream kinase (JNKK2) specific for activation of JNK (Fig. 5) as well as RNA interference of SEK1 (Fig. 6). We also found that DATS-mediated degradation of ferritin and release of labile iron are reduced markedly by interference of JNK activation (Figs. 5 and 6). Thus, it is reasonable to conclude that JNK signaling regulates stability of ferritin. A role for JNK in regulation of stability of several other proteins, including c-jun and c-myc, has been documented (48, 49).

In conclusion, the present study reveals that the DATS-induced ROS generation, which is a critical event in cell cycle arrest caused by this cancer chemopreventive agent (22), is mediated by an increase in labile iron due to proteasome-mediated degradation of ferritin. In addition, we provide experimental evidence to indicate involvement of JNK signaling axis in DATS-induced ROS production. To the best of our knowledge, the present study is the first published report to explain the mechanism by which JNK signaling may regulate cellular iron homeostasis and ROS production.


   Acknowledgments
 
Grant support: National Cancer Institute/USPHS grants CA113363 and CA115498.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

We thank Dr. Michael Karin (University of California, San Diego, CA) for generous gift of plasmid expressing catalytically inactive mutant of JNKK2 and Dr. Yong J. Lee (University of Pittsburgh, Pittsburgh, PA) for the generous gift of pSilencer and siSEK1#2 cells.

Received 1/30/06. Revised 3/11/06. Accepted 3/17/06.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. You WC, Blot WJ, Chang YS, et al. Allium vegetables and reduced risk of stomach cancer. J Natl Cancer Inst 1989;18:162–4.
  2. Gao CM, Takezaki T, Ding JH, Li MS, Tajima K. Protective effect of Allium vegetables against both esophageal and stomach cancer: a simultaneous case-referent study of a high-epidemic area in Jiangsu Province, China. Jpn J Cancer Res 1999;90:614–21.[CrossRef]
  3. Fleischauer AT, Poole C, Arab L. Garlic consumption and cancer prevention: meta-analyses of colorectal and stomach cancers. Am J Clin Nutr 2000;72:1047–52.[Abstract/Free Full Text]
  4. Hsing AW, Chokkalingam AP, Gao YT, et al. Allium vegetables and risk of prostate cancer: a population-based study. J Natl Cancer Inst 2002;94:1648–51.[Abstract/Free Full Text]
  5. Block E. The organosulfur chemistry of the genus Allium: implications for the organic chemistry of sulfur. Angew Chem Int Ed Engl 1992;31:1135–78.[CrossRef]
  6. Milner JA. A historical perspective on garlic and cancer. J Nutr 2001;131:1027–31s.
  7. Wargovich MJ. Diallyl sulfide, a flavor component of garlic (Allium sativum), inhibits dimethylhydrazine-induced colon cancer. Carcinogenesis 1987;8:487–9.[Abstract/Free Full Text]
  8. Sparnins VL, Barany G, Wattenberg LW. Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis 1988;9:131–4.[Abstract/Free Full Text]
  9. Wargovich MJ, Woods C, Eng VWS, Stephens LC, Gray K. Chemoprevention of N-nitrosomethylbenzylamine-induced esophageal cancer in rats by the naturally occurring thioether, diallyl sulfide. Cancer Res 1988;48:6872–5.[Abstract/Free Full Text]
  10. Reddy BS, Rao CV, Rivenson A, Kelloff G. Chemoprevention of colon carcinogenesis by organosulfur compounds. Cancer Res 1993;53:3493–8.[Abstract/Free Full Text]
  11. Schaffer EM, Liu JZ, Green J, Dangler CA, Milner JA. Garlic and associated allyl sulfur components inhibit N-methyl-N-nitrosourea induced rat mammary carcinogenesis. Cancer Lett 1996;102:199–204.[CrossRef][Medline]
  12. Hu X, Benson PJ, Srivastava SK, et al. Glutathione S-transferases of female A/J mouse liver and forestomach and their differential induction by anti-carcinogenic organosulfides from garlic. Arch Biochem Biophys 1996;336:199–214.[CrossRef][Medline]
  13. Singh SV, Pan SS, Srivastava SK, et al. Differential induction of NAD(P)H:quinone oxidoreductase by anti-carcinogenic organosulfides from garlic. Biochem Biophys Res Commun 1998;244:917–20.[CrossRef][Medline]
  14. Brady JF, Ishizaki H, Fukuto JM, et al. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites. Chem Res Toxicol 1991;4:642–7.[CrossRef][Medline]
  15. Singh SV. Impact of garlic organosulfides on p21(H-ras) processing. J Nutr 2001;131:1046–8s.
  16. Sundaram SG, Milner JA. Diallyl disulfide induces apoptosis of human colon tumor cells. Carcinogenesis 1996;17:669–73.[Abstract/Free Full Text]
  17. Knowles LM, Milner JA. Diallyl disulfide inhibits p34(cdc2) kinase activity through changes in complex formation and phosphorylation. Carcinogenesis 2000;21:1129–34.[Abstract/Free Full Text]
  18. Lan H, Lu Y. Allitridi induces apoptosis by affecting Bcl-2 expression and caspase-3 activity in human gastric cancer cells. Acta Pharmacol Sin 2004;25:219–25.[Medline]
  19. Filomeni G, Aquilano K, Rotilio G, Ciriolo MR. Reactive oxygen species-dependent c-Jun NH2-terminal kinase/c-Jun signaling cascade mediates neuroblastoma cell death induced by diallyl disulfide. Cancer Res 2003;63:5940–9.[Abstract/Free Full Text]
  20. Xiao D, Choi S, Johnson DE, et al. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene 2004;23:5594–606.[CrossRef][Medline]
  21. Herman-Antosiewicz A, Singh SV. Signal transduction pathways leading to cell cycle arrest and apoptosis induction in cancer cells by Allium vegetable-derived organosulfur compounds: a review. Mutat Res 2004;555:121–31.[Medline]
  22. Xiao D, Herman-Antosiewicz A, Antosiewicz J, et al. Diallyl trisulfide-induced G2-M phase cell cycle arrest in human prostate cancer cells is caused by reactive oxygen species-dependent destruction and hyperphosphorylation of Cdc25C. Oncogene 2005;24:6256–68.[CrossRef][Medline]
  23. Herman-Antosiewicz A, Singh SV. Checkpoint kinase 1 regulates diallyl trisulfide-induced mitotic arrest in human prostate cancer cells. J Biol Chem 2005;280:28519–28.[Abstract/Free Full Text]
  24. Hosono T, Fukao T, Ogihara J, et al. Diallyl trisulfide suppresses the proliferation and induces apoptosis of human colon cancer cells through oxidative modification of ß-tubulin. J Biol Chem 2005;280:41487–93.[Abstract/Free Full Text]
  25. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000;103:239–52.[CrossRef][Medline]
  26. Tyagi A, Agarwal R, Agarwal C. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis. Oncogene 2003;22:1302–16.[CrossRef][Medline]
  27. Hundley TR, Rigas B. Nitric oxide-donating aspirin inhibits colon cancer cell growth via mitogen-activated protein kinase activation. J Pharmacol Exp Ther 2006;316:25–34.[Abstract/Free Full Text]
  28. Bode AM, Dong Z. Targeting signal transduction pathways by chemopreventive agents. Mutat Res 2004;555:33–51.[Medline]
  29. Rothe G, Valet GJ. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2',7'-dichlorofluorescin. J Leukoc Biol 1990;47:440–8.[Abstract]
  30. Narayanan PK, Goodwin EH, Lehnert BE. Alpha particles initiate biological production of superoxide anions and hydrogen peroxide in human cells. Cancer Res 1997;57:3963–71.[Abstract/Free Full Text]
  31. Singh SV, Herman-Antosiewicz A, Singh AV, et al. Sulforaphane-induced G2/M phase cell cycle arrest involves checkpoint kinase 2 mediated phosphorylation of Cdc25C. J Biol Chem 2004;279:25813–22.[Abstract/Free Full Text]
  32. Singh SV, Srivastava SK, Choi S, et al. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J Biol Chem 2005;280:19911–24.[Abstract/Free Full Text]
  33. Choi S, Singh SV. Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable derived cancer chemopreventive agent. Cancer Res 2005;65:2035–43.[Abstract/Free Full Text]
  34. Gower JD, Healing G, Green CJ. Determination of desferrioxamine-available iron in biological tissues by high-pressure liquid chromatography. Anal Biochem 1989;180:126–30.[CrossRef][Medline]
  35. Breuer W, Epsztejn S, Millgram P, Cabantchik IZ. Transport of iron and other transition metals into cells as revealed by a fluorescent probe. Am J Physiol 1995;268:C1354–61.[Medline]
  36. Chen CY, Del Gatto-Konczak F, Wu Z, Karin M. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science 1998;280:1945–9.[Abstract/Free Full Text]
  37. Song JJ, Lee YJ. Dissociation of Akt1 from its negative regulator JIP1 is mediated through the ASK1-MEK-JNK signal transduction pathway during metabolic oxidative stress: a negative feedback loop. J Cell Biol 2005;170:61–72.[Abstract/Free Full Text]
  38. Kakhlon O, Cabantchik ZI. The labile iron pool: characterization, measurement, and participation in cellular processes. Free Radic Biol Med 2002;33:1037–46.[CrossRef][Medline]
  39. Kruszewski M. Labile iron pool: the main determinant of cellular response to oxidative stress. Mutat Res 2003;531:81–92.[Medline]
  40. Reif DW. Ferritin as a source of iron for oxidative damage. Free Radic Biol Med 1992;12:417–27.[CrossRef][Medline]
  41. Truty J, Malpe R, Linder MC. Iron prevents ferritin turnover in hepatic cells. J Biol Chem 2001;276:48775–80.[Abstract/Free Full Text]
  42. Ventura JJ, Cogswell P, Flavell RA, Baldwin AS, Davis RJ. JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes Dev 2004;18:2905–15.[Abstract/Free Full Text]
  43. Kim WH, Lee JW, Gao B, Jung MH. Synergistic activation of JNK/SAPK induced by TNF-{alpha} and IFN-{gamma}: apoptosis of pancreatic ß-cells via the p53 and ROS pathway. Cell Signal 2005;17:1516–32.[CrossRef][Medline]
  44. Wu Z, Wu J, Jacinto E, Karin M. Molecular cloning and characterization of human JNKK2, a novel Jun NH2-terminal kinase-specific kinase. Mol Cell Biol 1997;17:7407–16.[Abstract/Free Full Text]
  45. Le NT, Richardson DR. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim Biophys Acta 2002;1603:31–46.[Medline]
  46. Picard V, Epsztejn S, Santambrogio P, Cabantchik ZI, Beaumont C. Role of ferritin in the control of the labile iron pool in murine erythroleukemia cells. J Biol Chem 1998;273:15382–6.[Abstract/Free Full Text]
  47. Kakhlon O, Gruenbaum Y, Cabantchik ZI. Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells. Blood 2001;97:2863–71.[Abstract/Free Full Text]
  48. Fuchs SY, Dolan L, Davis RJ, Ronai Z. Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. Oncogene 1996;13:1531–5.[Medline]
  49. Alarcon-Vargas D, Ronai Z. c-Jun-NH2 kinase (JNK) contributes to the regulation of c-Myc protein stability. J Biol Chem 2004;279:5008–16.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 MutagenesisHome page
S. Nazeem, A. S. Azmi, S. Hanif, A. Ahmad, R. M. Mohammad, S. M. Hadi, and K. S. Kumar
Plumbagin induces cell death through a copper-redox cycle mechanism in human cancer cells
Mutagenesis, September 1, 2009; 24(5): 413 - 418.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S.-W. Shin, C.-Y. Seo, H. Han, J.-Y. Han, J.-S. Jeong, J.-Y. Kwak, and J.-I. Park
15d-PGJ2 Induces Apoptosis by Reactive Oxygen Species-mediated Inactivation of Akt in Leukemia and Colorectal Cancer Cells and Shows In vivo Antitumor Activity
Clin. Cancer Res., September 1, 2009; 15(17): 5414 - 5425.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K.-H. Zhang, H.-Y. Tian, X. Gao, W.-W. Lei, Y. Hu, D.-M. Wang, X.-C. Pan, M.-L. Yu, G.-J. Xu, F.-K. Zhao, et al.
Ferritin Heavy Chain-Mediated Iron Homeostasis and Subsequent Increased Reactive Oxygen Species Production Are Essential for Epithelial-Mesenchymal Transition
Cancer Res., July 1, 2009; 69(13): 5340 - 5348.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D.-H. Kim, J.-H. Kim, E.-H. Kim, H.-K. Na, Y.-N. Cha, J. H. Chung, and Y.-J. Surh
15-Deoxy-{Delta}12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS
Carcinogenesis, April 1, 2009; 30(4): 645 - 654.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. V. Singh, A. A. Powolny, S. D. Stan, D. Xiao, J. A. Arlotti, R. Warin, E.-R. Hahm, S. W. Marynowski, A. Bommareddy, D. M. Potter, et al.
Garlic Constituent Diallyl Trisulfide Prevents Development of Poorly Differentiated Prostate Cancer and Pulmonary Metastasis Multiplicity in TRAMP Mice
Cancer Res., November 15, 2008; 68(22): 9503 - 9511.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
G. Filomeni, G. Rotilio, and M. R. Ciriolo
Molecular Transduction Mechanisms of the Redox Network Underlying the Antiproliferative Effects of Allyl Compounds from Garlic
J. Nutr., November 1, 2008; 138(11): 2053 - 2057.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Xiao, A. A. Powolny, and S. V. Singh
Benzyl Isothiocyanate Targets Mitochondrial Respiratory Chain to Trigger Reactive Oxygen Species-dependent Apoptosis in Human Breast Cancer Cells
J. Biol. Chem., October 31, 2008; 283(44): 30151 - 30163.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
H. Nian, B. Delage, J. T. Pinto, and R. H. Dashwood
Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter
Carcinogenesis, September 1, 2008; 29(9): 1816 - 1824.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. Hosono, T. Hosono-Fukao, K. Inada, R. Tanaka, H. Yamada, Y. Iitsuka, T. Seki, I. Hasegawa, and T. Ariga
Alkenyl group is responsible for the disruption of microtubule network formation in human colon cancer cell line HT-29 cells
Carcinogenesis, July 1, 2008; 29(7): 1400 - 1406.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. J. Munoz-Alonso, L. Gonzalez-Santiago, N. Zarich, T. Martinez, E. Alvarez, J. M. Rojas, and A. Munoz
Plitidepsin Has a Dual Effect Inhibiting Cell Cycle and Inducing Apoptosis via Rac1/c-Jun NH2-Terminal Kinase Activation in Human Melanoma Cells
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1093 - 1101.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Li, E. Abdel Fattah, G. Cao, C. Ren, G. Yang, A. A. Goltsov, A. C. Chinault, W.-W. Cai, T. L. Timme, and T. C. Thompson
Glioma Pathogenesis-Related Protein 1 Exerts Tumor Suppressor Activities through Proapoptotic Reactive Oxygen Species c-Jun NH2 Kinase Signaling
Cancer Res., January 15, 2008; 68(2): 434 - 443.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
E.-R. Hahm and S. V. Singh
Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity
Mol. Cancer Ther., October 1, 2007; 6(10): 2686 - 2695.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y.-A. Kim, D. Xiao, H. Xiao, A. A. Powolny, K. L. Lew, M. L. Reilly, Y. Zeng, Z. Wang, and S. V. Singh
Mitochondria-mediated apoptosis by diallyl trisulfide in human prostate cancer cells is associated with generation of reactive oxygen species and regulated by Bax/Bak
Mol. Cancer Ther., May 1, 2007; 6(5): 1599 - 1609.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
A. Herman-Antosiewicz, S. D. Stan, E.-R. Hahm, D. Xiao, and S. V. Singh
Activation of a novel ataxia-telangiectasia mutated and Rad3 related/checkpoint kinase 1-dependent prometaphase checkpoint in cancer cells by diallyl trisulfide, a promising cancer chemopreventive constituent of processed garlic
Mol. Cancer Ther., April 1, 2007; 6(4): 1249 - 1261.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Xiao, K. L. Lew, Y.-A. Kim, Y. Zeng, E.-R. Hahm, R. Dhir, and S. V. Singh
Diallyl Trisulfide Suppresses Growth of PC-3 Human Prostate Cancer Xenograft In vivo in Association with Bax and Bak Induction.
Clin. Cancer Res., November 15, 2006; 12(22): 6836 - 6843.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Antosiewicz, J.
Right arrow Articles by Singh, S. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antosiewicz, J.
Right arrow Articles by Singh, S. V.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online